학술논문
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib
Document Type
Journal
Author
Engelman, Jeffrey A.; Zejnullahu, Kreshnik; Gale, Christopher-Michael; Lifshits, Eugene; Gonzales, Andrea J.; Shimamura, Takeshi; Zhao, Feng; Vincent, Patrick W.; Naumov, George N.; Bradner, James E.; Althaus, Irene W.; Gandhi, Leena; Shapiro, Geoffrey I.; Nelson, James M.; Heymach, John V.; Meyerson, Matthew; Wong, Kwok-Kin; Janne, Pasi A.
Source
Subject
Language
English
ISSN
00085472